About us

TFS HealthScience is a leading global mid-size Contract Research
Organization (CRO) that partners with biotechnology and pharmaceutical companies throughout their entire clinical development journey.

Clinical research excellence

We aim for excellence in clinical research by fulfilling the broad scope of expectations of healthcare innovators. With TFS, our customers can expect more. From scientific expertise and customer focus to tailored flexible solutions and consistent quality throughout the entire clinical development process. Together with customers, we build solution-driven partnerships based on mutual trust and reliability.

  • icon

    Trust

    It's about confidence, reliability, and fulfilling expectations at every stage.

  • icon

    Quality

    This is our standard and constant objective: quality of performance, delivery, and results.

  • icon

    Flexibility

    Supporting clients throughout their development journey, responding to challenges with agility focused on a successful outcome.

  • icon

    Passion

    Our professionalism is fueled by dedication and a desire to deliver excellence.

Our journey began over 25 years ago in Sweden, in the city of Lund. As a global CRO with the ultimate goal of ensuring patients' safety and well-being, we provide biotechnology and pharmaceutical companies with tailored clinical development solutions.

Expect more

TFS aims to exceed expectations from the early stages of the project all the way to study close-out. We prove to our clients that we are the right people with the right solutions at every phase of development.

  • Scientific excellence and focus

    TFS brings you dexterous and experienced team members dedicated to the project and supported by robust strategies.

  • Strategic partnership

    Close collaboration with our clients and key opinion leaders is a cornerstone of our approach.

  • Consistent delivery

    Ensuring compliance, detailed oversight, appropriate expertise, and unwavering commitment at every stage of the project.

  • Socially and ethically responsible practices

    TFS is committed to delivering high quality services ethically and sustainably. Read more.

Corporate Social Responsibility

We consider social responsibility and sustainability a priority for TFS. Here we present our progress and commitment to continuous improvement.

Read more

Global presence

Our history

1996

TFS is founded in Lund, Sweden

1997

TFS is the first CRO in Europe to establish a Functional Service (FSP) business

2001

TFS opens its office in Copenhagen, Denmark

2003

TFS establishes Phase I operations in an agreement with the Karolinska University Hospital, Stockholm, Sweden, for First-In-Man studies, special patient populations, and PET imaging services

2004

TFS Academy conducts its first clinical research education courses

2005

  • TFS acquires CDC Clinical Data Care to strengthen regulatory, pharmacovigilance and medical writing services
  • TFS expands into Spain through the acquisition of Clinical Data Care, Spain
  • TFS opens its office in Uxbridge, UK

2007

TFS opens its office in Tokyo, Japan

2008

  • TFS acquires IMRO-TRAMARKO, the first established CRO in the Netherlands and expands operations to Benelux and Germany
  • TFS opens its first US office, in Cambridge, Massachusetts

2012

  • TFS acquires Dimensione Ricerca S.r.l, the first established CRO in Italy
  • TFS opens its office in Paris, France

2013

  • TFS acquires Beardsworth Consulting Group in the US, an Oncology and Vaccine niche CRO
  • TFS acquires cost-efficient EDC solution from SEMCON in Sweden
  • TFS opens office in Germany

2014

TFS starts operations in Canada

2015

TFS agrees to divest 60% of shares to Ratos

2016

  • TFS acquires SCIderm, a dermatology specialist CRO and expands operations in Germany
  • TFS awarded Excellence in innovation at Omnicom Innovation Forum for the development of an in-house Protocol Deviation module

2017

TFS’ Dermatology Team awarded the Top Job Seal for outstanding employer qualities

2018

TFS Strengthens Strategic Planning Capabilities with Citeline

2019

  • Ratos acquires remaining 40% of shares in TFS
  • TFS joins Medidata Partner Program with Rave EDC accreditation

2020

  • TFS partners with Veeva to offer safety database solution for its trials
  • TFS partners with the Duke Clinical Research Institute (DCRI) to provide data management solutions across the academic research organization’s study portfolio